Abstract
Human osteoarthritis (OA) is a complex multi-factorial disease that primarily targets the cartilage. The cartilage is a specialized tissue where the chondrocytes maintain matrix homeostasis. The paradigm for the post genomic era of molecular medicine is to identify the function of defective genes associated with specific diseases. Although the process of identification and validation of target genes is feasible with the available tools and technologies, establishing the link between defected gene products and the disease is still a challenging task. New tools in genomic analysis not only allow us to profile gene expression in normal and diseased tissues, but also facilitate the development of unbiased hypothesis at the molecular level. Several defective heritable genes encoding the matrix components (such as Col2a1 and Col9a1 that code for type II and IX collagen respectively) have been linked to the development of OA in human and animal models. Several families of genes expressed differentially in normal and osteoarthritis-affected cartilage have been identified. These include matrix metalloproteinases (MMPs), matrix proteins, integrins, transcription factors, cytokines, cytokine receptors, growth factors and homeostatic genes. A non-conventional functional genomic approach is required to study the complexity of chondrocyte and matrix interactions that affect the above mentioned targets.
Keywords: osteoarthritis, human osteoarthritis, matrix protein, oa, integrin, metalloproteinase
Current Genomics
Title: Gene Mining and Functional Genomics in Human Osteoarthritis
Volume: 4 Issue: 2
Author(s): M. G. Attur, M. N. Dave and A. R. Amin
Affiliation:
Keywords: osteoarthritis, human osteoarthritis, matrix protein, oa, integrin, metalloproteinase
Abstract: Human osteoarthritis (OA) is a complex multi-factorial disease that primarily targets the cartilage. The cartilage is a specialized tissue where the chondrocytes maintain matrix homeostasis. The paradigm for the post genomic era of molecular medicine is to identify the function of defective genes associated with specific diseases. Although the process of identification and validation of target genes is feasible with the available tools and technologies, establishing the link between defected gene products and the disease is still a challenging task. New tools in genomic analysis not only allow us to profile gene expression in normal and diseased tissues, but also facilitate the development of unbiased hypothesis at the molecular level. Several defective heritable genes encoding the matrix components (such as Col2a1 and Col9a1 that code for type II and IX collagen respectively) have been linked to the development of OA in human and animal models. Several families of genes expressed differentially in normal and osteoarthritis-affected cartilage have been identified. These include matrix metalloproteinases (MMPs), matrix proteins, integrins, transcription factors, cytokines, cytokine receptors, growth factors and homeostatic genes. A non-conventional functional genomic approach is required to study the complexity of chondrocyte and matrix interactions that affect the above mentioned targets.
Export Options
About this article
Cite this article as:
Attur G. M., Dave N. M. and Amin R. A., Gene Mining and Functional Genomics in Human Osteoarthritis, Current Genomics 2003; 4 (2) . https://dx.doi.org/10.2174/1389202033350056
DOI https://dx.doi.org/10.2174/1389202033350056 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bone Marrow Microenvironment: A Newly Recognized Target for Diabetes- Induced Cellular Damage
Endocrine, Metabolic & Immune Disorders - Drug Targets Editorial [Hot Topic: Why Apoptosis in Pediatric Disorders?]
Current Pediatric Reviews Editorial (Thematic Issue: Neurobiological and Neurocognitive Basis of the Effects of Cannabinoids in Animals and Man: Therapeutic Potential of Cannabinoids in Psychiatry)
Current Pharmaceutical Design Metal and Inflammatory Targets for Alzheimers Disease
Current Drug Targets Carbohydrate Antigens: Synthesis Aspects and Immunological Applications in Cancer
Mini-Reviews in Medicinal Chemistry Vascular Oxidative Stress and Mitochondrial Failure in the Pathobiology of Alzheimer’s Disease: A New Approach to Therapy
CNS & Neurological Disorders - Drug Targets Nitric Oxide and Cardiovascular Dysfunction in Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Drug Metabolizing Enzymes in the Perinatal and Neonatal Period: Differences in the Expression and Activity
Current Drug Metabolism Gene Expression Profiles in Human Autoimmune Disease
Current Pharmaceutical Design Cationic Liposome Mediated Delivery of FUS1 and hIL-12 Coexpression Plasmid Demonstrates Enhanced Activity against Human Lung Cancer
Current Cancer Drug Targets A Review of <i>Aristolochia indica</i>: Ethnomedicinal Uses, Phytochemistry, Pharmacological and Toxicological Effects
Current Traditional Medicine Neuroimmune Aspects of Sjogren`s Syndrome: Role of VIP/VPAC System in Immune and Salivary Gland Epithelial Cell Function
Current Pharmaceutical Design Pharmacotherapy in Neonatal and Pediatric Extracorporeal Membrane Oxygenation (ECMO)
Current Drug Metabolism Clinical Observation of Liver Chemistry Abnormalities in Asthmatics
Current Drug Safety Antioxidant, Anti-Inflammatory and Anticancer Activities of the Methanolic Extract of Thottea siliquosa: An <i>In Vitro</i> and <i>In Silico</i> Study
Recent Patents on Anti-Cancer Drug Discovery Vitamin D status in coronary artery disease: association with IL-35 and TGF-β1 and disease severity
Endocrine, Metabolic & Immune Disorders - Drug Targets Antitumoral Potential of Snake Venom Phospholipases A2 and Synthetic Peptides
Current Pharmaceutical Biotechnology Bioactivities of Iridoids
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Role and Predictive Value of Cytokines in Atherosclerosis and Coronary Artery Disease
Current Medicinal Chemistry The Role of Chemokines in Alzheimer's Disease
Endocrine, Metabolic & Immune Disorders - Drug Targets